Skip to main content
Westbury, NY – Oct. 16, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired PPA Research Group, Inc., a human hematologic product provider, based in Gray, TN. This acquisition will significantly expand BioIVT’s immunology and disease-state product portfolios, enhancing its ability to support immuno-oncology and cell therapy researchers. PPA Research Group operates full-service donor centers in Johnson City, TN and Berkeley, CA focused primarily on producing leukopaks. Leukopaks contain concentrated…
The website for Integrated Biologix (www.ibiologix.com), a fully integrated non-clinical development consultancy for biotherapeutics goes live.
LOUGHBOROUGH, England (October 14, 2019) – Science World, the Fisher Scientific Laboratory Experience, made a successful debut at Leicester Tigers Rugby Club on 10 October. The event, hosted by Thermo Fisher Scientific, showcased the latest in laboratory innovations available through the Fisher Scientific channel. Thousands of products were available for attendees to experience, making it an ideal event for anyone working in or around a laboratory. Highlights from Science World included the following keynote speakers: Jamie Gallagher who presented “Uncovering the secrets of nanotechnology,”…
AMSBIO announces two new Luciferase assay kits designed to help you improve your gene reporter assays.Gene reporter assays are widely used in research and drug discovery. The development of such cell lines is often time-consuming and costly. Once these cell lines are finally validated, why jeopardize your results with cheap and low-end detection kits that can impact the reproducibility of your experiments in unintended and unanticipated ways. Two reliable and extremely powerful luciferase detection kits - the One-Step Luciferase Assay System and the Dual Luciferase…
Cambridge, UK – 16 October, 2019 – Healx, the AI-powered and patient-inspired technology company specialising in treatments for rare diseases, today announces that it has raised $56 million in a Series B financing round, led by one of Europe’s largest VC firms Atomico and joined by Intel Capital, Global Brain and btov Partners. All previous investors, including Balderton Capital, Amadeus Capital Partners, and Jonathan Milner also participated in the round. The financing will be used to develop the company’s therapeutic pipeline and to launch its global Rare Treatment Accelerator programme.…
Cambridge, UK, 14th October 2019: Mogrify Ltd (Mogrify), a UK company aiming to transform the development of life-saving cell therapies, today announced the initial close of its Series A funding. The Company raised $16 million USD in this round, bringing the total investment to over $20 million USD to date. The funding will support internal cell therapy programs, and the development and out-license of novel IP relating to cell conversions of broad therapeutic interest. Mogrify is also actively recruiting, and will increase headcount to 60 scientific, operational and commercial staff located…
Cambridge UK: 11 October 2019 GlobalData has become the latest Partner to join forces with One Nucleus. The One Nucleus Partner Programme is tailor-made to meet the needs both of the Partner and the interests of One Nucleus members.Saief Kazmi, Account Director commented ‘GlobalData are committed to supporting innovation and advances in healthcare and we are delighted to partner with One Nucleus and the magnificent cluster of talent and scientific acumen. Should members be seeking partners, new clients, funding or looking to better understand existing or new therapy areas our…
Clinical Professionals fully fund and train some of the UK’s brightest life science graduates with the aim of giving back and assisting in the future of the industry talent pool and future skilled professionals.The Parliamentary Review, co-chaired by former ministers Lord Pickles and Lord Blunkett, publishes its latest, highly anticipated edition this September. Featuring commentary from the prime minister and senior politicians alongside business and thought leaders across both the private and public sectors, The Review aims to share and promote best practice among executives and…
Reading Scientific Services Ltd (RSSL) secures Enlighted Employer Award in recognition of its exceptional commitment to gender equality in the workplace. RSSL was named most Enlightened Employer at this year’s Women in Business Awards; a Thames Valley initiative set up to empower businesswomen and showcase organisations that “create a better balance for better business.” With female employees making up 65% of its 300 staff, a female majority in its leadership team and inspirational female role models at every level, RSSL successfully demonstrated itself to be “a truly worthy winner”…
Nadhim Zahawi MP has announced that Stevenage Bioscience Catalyst (SBC) has been successful in its application to become a Life Science Opportunity Zone. The assessment panel consisted of senior industry life science experts and senior government officials. In a letter to Stevenage Bioscience Catalyst Chief Executive Officer Dr Sally Ann Forsyth, the Minister stated: “l am delighted to tell you that your application has been successful. The panel were impressed by your plans to grow what is already a successful biomedical campus.” The Minister made the formal announcement at Hertfordshire…